AXM Pharma Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. AXM Pharma prevailing Real Value cannot be determined due to lack of data. The current price of AXM Pharma is $0.0. Our model approximates the value of AXM Pharma from analyzing the firm fundamentals such as Shares Outstanding of 10.41 B, profit margin of 0.08 %, and Current Valuation of 28.73 M as well as examining its technical indicators and probability of bankruptcy.
AXM Pharma Total Value Analysis
AXM Pharma is presently expected to have valuation of 28.73 M with market capitalization of 10.41 K, debt of 3.61 M, and cash on hands of 1.66 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the AXM Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
28.73 M | 10.41 K | 3.61 M | 1.66 M |
AXM Pharma Investor Information
The company had not issued any dividends in recent years. AXM Pharma had 2:1 split on the 12th of April 2001. Based on the key measurements obtained from AXM Pharma's financial statements, AXM Pharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.AXM Pharma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of AXM connotes not a very effective usage of assets in December.AXM Pharma Profitability Analysis
The company reported the previous year's revenue of 113.08 M. Net Income was 8.18 M with profit before overhead, payroll, taxes, and interest of 20.08 M.AXM Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as AXM Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 159 M | |
| Price Earnings Ratio | 0.0005 | |
| Retained Earnings | 30.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in AXM Stock
If you are still planning to invest in AXM Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AXM Pharma's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |